Cas no 16176-73-1 (2-(1H-Indol-4-yl)ethanamine)

2-(1H-Indol-4-yl)ethanamine is a bioactive indole derivative characterized by an ethylamine substituent at the 4-position of the indole ring. This compound serves as a valuable intermediate in organic synthesis, particularly in the development of pharmaceuticals and agrochemicals. Its indole core structure is significant due to its prevalence in biologically active molecules, including neurotransmitters and alkaloids. The presence of the primary amine group enhances its reactivity, enabling facile derivatization for applications in medicinal chemistry and drug discovery. The compound's stability and well-defined synthetic pathway make it a reliable building block for researchers exploring novel indole-based compounds. Proper handling under controlled conditions is recommended due to its potential sensitivity.
2-(1H-Indol-4-yl)ethanamine structure
2-(1H-Indol-4-yl)ethanamine structure
Product Name:2-(1H-Indol-4-yl)ethanamine
CAS No:16176-73-1
MF:C10H12N2
MW:160.215682029724
MDL:MFCD08449200
CID:50354
PubChem ID:13100901
Update Time:2025-10-24

2-(1H-Indol-4-yl)ethanamine Chemical and Physical Properties

Names and Identifiers

    • 2-(1H-Indol-4-yl)ethanamine
    • 2-(1H-Indol-4-yl)ethylamine
    • 1H-Indole-4-ethanamine
    • BS-21661
    • W-205881
    • 16176-73-1
    • AMY17979
    • A3585
    • 2-(1H-indol-4-yl)-ethylamine
    • FT-0706840
    • EN300-118880
    • A883061
    • 4-[(2-amino)ethyl]indole
    • XBARKDQKGSJDLG-UHFFFAOYSA-N
    • SCHEMBL2239944
    • CS-0096233
    • 2-(1H-Indol-4-yl)ethan-1-amine
    • Indole-4-ethylamine
    • AKOS004122057
    • DTXSID40518154
    • DB-064411
    • ALBB-037363
    • MDL: MFCD08449200
    • Inchi: 1S/C10H12N2/c11-6-4-8-2-1-3-10-9(8)5-7-12-10/h1-3,5,7,12H,4,6,11H2
    • InChI Key: XBARKDQKGSJDLG-UHFFFAOYSA-N
    • SMILES: N1C=CC2=C1C=CC=C2CCN

Computed Properties

  • Exact Mass: 160.10000
  • Monoisotopic Mass: 160.100048391g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 2
  • Complexity: 147
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.4
  • Topological Polar Surface Area: 41.8?2

Experimental Properties

  • Density: 1.157
  • Boiling Point: 342.5 ℃ at 760 mmHg
  • Flash Point: 187.7 °C
  • Refractive Index: 1.668
  • PSA: 41.81000
  • LogP: 2.36940

2-(1H-Indol-4-yl)ethanamine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM148516-1g
2-(1H-Indol-4-yl)ethanamine
16176-73-1 95%
1g
$795 2021-08-05
TRC
I655725-10mg
2-(1H-Indol-4-yl)ethanamine
16176-73-1
10mg
$ 50.00 2022-06-04
TRC
I655725-50mg
2-(1H-Indol-4-yl)ethanamine
16176-73-1
50mg
$ 185.00 2022-06-04
TRC
I655725-100mg
2-(1H-Indol-4-yl)ethanamine
16176-73-1
100mg
$ 275.00 2022-06-04
Chemenu
CM148516-1g
2-(1H-Indol-4-yl)ethanamine
16176-73-1 95%
1g
$710 2023-02-02
eNovation Chemicals LLC
D553793-1g
2-(1H-Indol-4-yl)ethanaMine
16176-73-1 97%
1g
$809 2025-02-21
eNovation Chemicals LLC
D553793-1g
2-(1H-Indol-4-yl)ethanaMine
16176-73-1 97%
1g
$809 2025-02-18
A2B Chem LLC
AA87772-5g
2-(1H-Indol-4-yl)ethanamine
16176-73-1 95%
5g
$2093.00 2024-04-20
A2B Chem LLC
AA87772-50mg
2-(1H-Indol-4-yl)ethanamine
16176-73-1 95%
50mg
$170.00 2024-01-03
A2B Chem LLC
AA87772-100mg
2-(1H-Indol-4-yl)ethanamine
16176-73-1 95%
100mg
$108.00 2024-04-20

Additional information on 2-(1H-Indol-4-yl)ethanamine

2-(1H-Indol-4-yl)ethanamine: A Comprehensive Overview

2-(1H-Indol-4-yl)ethanamine, also known by its CAS number 16176-73-1, is a compound of significant interest in the fields of organic chemistry, pharmacology, and materials science. This molecule, characterized by its indole ring structure and ethanamine side chain, has garnered attention due to its unique chemical properties and potential applications in drug discovery and advanced materials. In this article, we delve into the structural features, synthesis methods, biological activities, and recent research advancements related to 2-(1H-Indol-4-yl)ethanamine.

The indole moiety in 2-(1H-Indol-4-yl)ethanamine is a bicyclic structure consisting of a six-membered benzene ring fused with a five-membered pyrrole ring. This arrangement imparts the molecule with aromatic stability and unique electronic properties. The ethanamine group attached at the 4-position of the indole ring introduces additional functional diversity, enabling the compound to participate in various chemical reactions and interactions. Recent studies have highlighted the importance of such structural features in modulating the biological activity of indole derivatives.

Synthesis and Characterization: The synthesis of 2-(1H-Indol-4-yl)ethanamine typically involves multi-step organic reactions. One common approach is the Friedlander synthesis, which utilizes an o-amino aryl aldehyde or ketone to form the indole ring. Subsequent functionalization introduces the ethanamine group at the desired position. Advanced characterization techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography have been employed to confirm the molecular structure and purity of this compound.

Biological Activity: 2-(1H-Indol-4-yl)ethanamine has demonstrated promising biological activity in various assays. Recent research has shown that this compound exhibits anti-inflammatory properties by inhibiting key enzymes involved in inflammatory pathways. Additionally, studies have explored its potential as an antioxidant agent, capable of neutralizing reactive oxygen species and protecting cells from oxidative damage.

Applications in Drug Discovery: The indole scaffold is a recurring theme in drug design due to its ability to interact with diverse biological targets. 2-(1H-Indol-4-yl)ethanamine has been investigated as a lead compound for developing therapies against neurodegenerative diseases, cancer, and infectious diseases. For instance, its ability to modulate ion channels has been explored in preclinical models of epilepsy.

Recent Research Advancements: In 2023, researchers reported novel synthetic routes for 2-(1H-Indol-4-yethylamino) that significantly enhance yield and reduce reaction time. These methods leverage catalytic asymmetric synthesis to produce enantiomerically pure compounds, which are crucial for pharmacological studies. Furthermore, computational modeling has been employed to predict the binding affinities of this compound to various protein targets, providing valuable insights into its mechanism of action.

Future Prospects: The versatility of 2-(1H-indolium) derivatives suggests that 2-(1H-indolium) will continue to be a focal point in chemical research. Ongoing studies aim to optimize its bioavailability and efficacy for therapeutic applications. Collaborative efforts between chemists and biologists are expected to unlock new potentials for this compound in areas such as personalized medicine and nanotechnology.

In conclusion, 2-(1H-indoline) stands out as a versatile molecule with significant implications across multiple disciplines. Its unique structure, coupled with recent advancements in synthesis and biological evaluation, positions it as a valuable tool for future innovations in science and medicine.

Recommended suppliers
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hunan Well Medicine Synthesis Technology Co., Ltd.